title: L42. Morbidity in patients with ANCA-associated vasculitis.
authors: University of Birmingham, Renal Immunobiology, Division of Immunity and Infection, Edgbaston, Birmingham B15 2TT, UK. l.harper@bham.ac.uk
authors: Lorraine
authors: L
authors: Harper
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality*; D002423:Cause of Death; D006470:Hemorrhage / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D008171:Lung Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D010038:Otorhinolaryngologic Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000401:mortality; D011650:Pulmonary Alveoli; D012307:Risk Factors; D015996:Survival Rate; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000401:mortality
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents